GlassScriptPhysician profile
Kevin D Mcintosh
NPI 1235367038
$2,916.35
in general payments reported to CMS, 2019-2025
33 companies · $839 in 2025
The $839 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $243 · 2021: $384 · 2022: $615 · 2023: $331 · 2024: $243 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025 · Honoraria: $350 · Education: $38.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.77 |
| Honoraria | $350.00 |
| Education | $38.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $374.09 | 2023-2025 | |
| Hologic Sales and Service, LLC | $324.33 | 2021-2025 | Aptima, Novasure |
| Abbvie INC. | $290.49 | 2019-2022 | |
| Astellas Pharma US INC | $211.76 | 2021-2025 | Veozah |
| Exeltis, USA INC. | $154.42 | 2019-2024 | Slynd |
| Pfizer INC. | $148.99 | 2019-2023 | |
| Aspira Women'S Health INC | $125.26 | 2020-2021 | |
| Channel Medsystems, INC. | $111.71 | 2022 | |
| Sumitomo Pharma America, INC. | $103.74 | 2023-2024 | Myfembree |
| Intuitive Surgical, INC. | $102.37 | 2020-2025 | |
| Boston Scientific Corporation | $96.65 | 2023-2025 | Solyx Sis System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Amag Pharmaceuticals, INC. | $95.98 | 2019-2020 | |
| Sage Therapeutics, LLC | $83.35 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $63.04 | 2022-2025 | |
| Myovant Sciences INC. | $62.35 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $56.12 | 2019-2025 | |
| Mylan Pharmaceuticals INC. | $55.67 | 2020-2022 | |
| Therapeuticsmd, INC. | $48.86 | 2019-2022 | |
| Coopersurgical, INC. | $46.38 | 2020-2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $42.31 | 2025 | Qelbree |
| Organon LLC | $41.34 | 2024 | |
| Lupin INC. | $36.44 | 2019-2020 | |
| Axonics, INC. | $35.91 | 2023-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $35.51 | 2023-2025 | |
| Ethicon US, LLC | $27.49 | 2025 | Ethicon, Stratafix |
| Baxter Healthcare | $22.24 | 2023 | Tisseel |
| Daiichi Sankyo INC. | $19.36 | 2020 | |
| Monaghan Medical Corporation | $18.80 | 2023 | Aerochamber |
| Becton, Dickinson and Company | $17.93 | 2022 | |
| Smith+Nephew, INC. | $17.90 | 2021 | |
| Scynexis, INC. | $17.43 | 2022 | |
| Coloplast Corp | $15.90 | 2021 | |
| Evofem Biosciences, INC. | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.